ST. LOUIS, May 13, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the launch of a novel scientific search engine designed to give researchers easier access to peer-reviewed articles and abstract information on the Company's website, sigma-aldrich.com. The new search engine allows scientists to immediately read the full text of millions of peer-reviewed papers without extra clicks or logins, discover applications for specific Sigma-Aldrich products in peer-reviewed literature, and provides free access to the Ingenuity gene and biological pathway database.
"We understand the value of validated products and data for use in research," said Amanda Halford, Vice President, Academic Research, Sigma-Aldrich. "Whether seeking inspiration, investigating how other scientists or laboratories performed experiments, validating the performance or utility of a product or finding supporting papers for experiments, these enhancements streamline the scientific search process and can help the research community find better information."
The access to full-text papers is powered by technology from Pubget, a solutions provider focused on expediting the acquisition and analysis of content. Searches can be initiated from the main search bar on the Sigma-Aldrich website.
"Pubget serves millions of researchers across hundreds of institutions, and as such we have seen a lot of information retrieval implementations. It's clear that by combining papers, products and technical data, researchers will quickly recognize the time savings," said Ryan Jones, Pubget Co-Founder. "The instant full-text display, coupled with the methods and gene data in this search tool, will allow scientists to spend less time searching and more time doing research."The biological search is powered by the Ingenuity Systems ® Platform using Target Explorer web services. Target Explorer furnishes unique biological content that is up-to-date, comprehensive and relevant to searches conducted by scientists through the Sigma-Aldrich website. "Building on five years of collaboration with Sigma-Aldrich, we are delighted to deliver innovative ways for users of the Sigma-Aldrich website to gain biological insights," said Tuan Nguyen, Vice President, Partner and Professional Services at Ingenuity Systems. "The collaboration will help biologists make more incisive decisions, regardless of whether they are reading full text articles, exploring biological interactions or making product selections." About Sigma-Aldrich: Sigma- Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma- Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 38 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma- Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com. Sigma- Aldrich is a trademark of Sigma-Aldrich Co, LLC registered in the US and other countries. Ingenuity Systems is a registered trademark of Ingenuity Systems, Inc. SOURCE Sigma-Aldrich Corporation
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV